Loading
Life sciences · Journal article
Biomedical Reports · October 15, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Childhood obesity, which is reaching alarming prevalence worldwide, is associated with long-term adverse metabolic and cardiovascular health outcomes and often persists into adulthood.Investigating the mechanisms responsible for weight gain in early life is essential to better understand and prevent obesity and its related comorbidities.Leptin is a hormone primarily secreted by adipocytes.It suppresses appetite and increases energy expenditure through neonatal programming of the hypothalamic neural circuits responsible for regulation of food intake.The mechanisms regulating leptinemia are not fully understood.MicroRNAs (miRNAs), short RNA molecules repressing protein synthesis of their target genes and secreted in bloodstream, may play a role.To identify circulating miRNAs whose levels are associated with leptinemia in umbilical cord plasma (UCP), the present study quantified the miRNAs from 273 newborns in the Gen3G prospective birth cohort using next-generation sequencing (NGS).A total of 73 miRNAs were associated with leptinemia (P≤0.05) in UCP.Of these, miR-183-5p and miR-155-5p were selected to be requantified by digital PCR for 201 of these newborns based on the strength of their association [Log 2 (fold-change)=0.22,P=0.0007 and Log 2 (fold-change)=-0.14,P=0.005, respectively].Association with leptinemia was replicated for miR-155-5p (Pearson correlations: NGS, r=-0.13,P=0.03; dPCR, r=-0.12,P=0.04).Biological pathways analysis showed that miR-155-5p is predicted to target the leptin receptor mRNA.These findings suggest miR-155-5p may influence leptinemia in UCP and contribute to early-life adiposity programming.